breast cancer
Showing NaN - NaN of 224
Ovarian Cancer, Breast Cancer Trial in Worldwide (Olaparib)
Enrolling by invitation
- Ovarian Cancer
- Breast Cancer
-
Boca Raton, Florida
- +98 more
Aug 22, 2022
Breast Cancer Trial in United States (Breast Cancer Index (BCI) Risk of Recurrence & Extended Endocrine Benefit Test)
Recruiting
- Breast Cancer
- Breast Cancer Index (BCI) Risk of Recurrence & Extended Endocrine Benefit Test
-
Daphne, Alabama
- +104 more
Aug 17, 2022
Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan, Capecitabine, Lapatinib)
Active, not recruiting
- Breast Cancer
- Trastuzumab deruxtecan
- +3 more
-
Chandler, Arizona
- +226 more
Aug 11, 2022
Cardiotoxicity, Toxicity Due to Chemo, Breast Cancer Trial in Duarte, Philadelphia, West Chester (Biomarker Guided Intervention)
Recruiting
- Cardiotoxicity
- +5 more
- Biomarker Guided Intervention
-
Duarte, California
- +2 more
Jul 29, 2022
MRI Background Parenchymal Enhancement asRisk Factor for Breast
Active, not recruiting
- Breast Cancer
-
Basking Ridge, New Jersey
- +6 more
Jul 20, 2022
Breast Cancer, Head Neck Cancer, Squamous Cell Carcinoma Trial in Canada, United States (INT230-6, anti-PD-1 antibody,
Active, not recruiting
- Breast Cancer
- +10 more
- INT230-6
- +2 more
-
Los Angeles, California
- +7 more
Jun 21, 2022
Breast Cancer Trial in Philadelphia (Bulk Order, Texting, Clinician Endorsement)
Completed
- Breast Cancer
- Bulk Order
- +4 more
-
Philadelphia, PennsylvaniaPenn Medicine
Jun 24, 2022
Quality of Life in Female Breast Cancer Survivors and Their
Completed
- Breast Cancer
- +5 more
- cognitive assessment
- +2 more
-
Monterey, California
- +103 more
Jun 8, 2022
The Breast Program - Translational Cancer Resource
Active, not recruiting
- Breast Cancer
- Biospecimen Collection
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Jun 1, 2022
Breast Cancer, Triple Negative Breast Cancer, Residual Cancer Trial in United States (Atezolizumab, Sacituzumab govitecan)
Recruiting
- Breast Cancer
- +3 more
- Atezolizumab
- Sacituzumab govitecan
-
San Francisco, California
- +8 more
May 25, 2022
Breast Cancer Trial in Worldwide (Amcenestrant-matching , SAR439859, Palbociclib)
Active, not recruiting
- Breast Cancer
- Amcenestrant-matching placebo
- +5 more
-
Daphne, Alabama
- +299 more
May 5, 2022
Cardiovascular Diseases, Breast Cancer, Prostate Cancer Trial in Duarte, Bronx, Philadelphia (Gamification and Social Support,
Recruiting
- Cardiovascular Diseases
- +3 more
- Gamification and Social Support
- Attention control
-
Duarte, California
- +2 more
May 4, 2022
Breast Cancer Trial in Worldwide (Palbociclib, Standard Adjuvant Endocrine Therapy)
Active, not recruiting
- Breast Cancer
- Palbociclib
- Standard Adjuvant Endocrine Therapy
-
Mobile, Alabama
- +437 more
Mar 21, 2022
Advanced Solid Tumor, Gynecologic Cancer, Breast Cancer Trial in United States (PY314, Combination Therapy: PY314 +
Recruiting
- Advanced Solid Tumor
- +8 more
- PY314
- Combination Therapy: PY314 + Pembrolizumab
-
Scottsdale, Arizona
- +12 more
Mar 28, 2022
Breast Cancer Trial in Tampa, Philadelphia (HER-2 pulsed Dendritic Cell Vaccine)
Active, not recruiting
- Breast Cancer
- HER-2 pulsed Dendritic Cell Vaccine
-
Tampa, Florida
- +1 more
Mar 23, 2022
Breast Cancer Trial in United States (Palbociclib, Aromatase Inhibitor)
Completed
- Breast Cancer
- Palbociclib
- Aromatase Inhibitor
-
San Francisco, California
- +9 more
Mar 18, 2022
Cardiotoxicity in Breast Cancer Patients Treated With Proton or
Enrolling by invitation
- Breast Cancer
- Cardiotoxicity
- Proton vs Photon Radiation
-
Birmingham, Alabama
- +5 more
Mar 4, 2022
Breast Cancer Trial in Philadelphia (MRI, Digital Mammography, Ultrasound and Positron Emission Tomography (PET))
Active, not recruiting
- Breast Cancer
- MRI, Digital Mammography, Ultrasound and Positron Emission Tomography (PET)
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Feb 28, 2022